Health Care & Life Sciences » Pharmaceuticals | WooGene B&G Co. Ltd.

WooGene B&G Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
20,546
22,087
23,507
27,819
26,434
Cost of Goods Sold (COGS) incl. D&A
13,287
13,214
15,514
19,597
20,502
Gross Income
7,259
8,873
7,993
8,221
5,932
SG&A Expense
6,425
7,941
7,914
8,003
9,231
EBIT
769
853
15
126
3,508
Unusual Expense
12
2
35
147
526
Non Operating Income/Expense
116
1
302
49
295
Interest Expense
182
179
243
276
1,089
Pretax Income
546
708
44
156
4,345
Income Tax
61
114
309
20
155
Consolidated Net Income
606
821
353
175
4,190
Net Income
606
821
353
175
4,190
Net Income After Extraordinaries
606
821
353
175
4,190
Net Income Available to Common
606
821
353
175
4,190
EPS (Basic)
49.94
65.60
30.34
13.78
331.82
Basic Shares Outstanding
12
13
12
13
13
EPS (Diluted)
50.02
65.49
30.11
13.41
331.65
Diluted Shares Outstanding
12
13
12
13
13
EBITDA
1,523
1,717
853
1,007
2,013
Other Operating Expense
65
79
94
92
210
Non-Operating Interest Income
87
33
34
111
21

About WooGene B&G Co.

View Profile
Address
230 Jeongmunsongsan-ro
Hwaseong GY 18629
Korea, Republic Of
Employees -
Website http://www.woogenebng.com
Updated 09/14/2018
WooGene B&G Co., Ltd. manufactures and sells veterinary pharmaceutical and nutraceutical products. It operates through the following divisions: Pharmaceuticals and Nutraceuticals. The Pharmaceutical division's products include anti-infective drugs, probiotics, anti-parasitics, hormone preparations, vaccines, anesthetics, teat dips, disinfectants, pet cure drugs, calcium injections, sedative injections, toxin binders and bacterial disease remedies.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.